User profiles for Jie Zhou

Jie Zhou

- Verified email at tsinghua.edu.cn - Cited by 32517

Jie Zhou

- Verified email at hku.hk - Cited by 9880

Jie Zhou

- Verified email at mails.tsinghua.edu.cn - Cited by 6039

[HTML][HTML] Graph neural networks: A review of methods and applications

J Zhou, G Cui, S Hu, Z Zhang, C Yang, Z Liu, L Wang… - AI open, 2020 - Elsevier
Lots of learning tasks require dealing with graph data which contains rich relation information
among elements. Modeling physics systems, learning molecular fingerprints, predicting …

Supramolecular hydrogelators and hydrogels: from soft matter to molecular biomaterials

X Du, J Zhou, J Shi, B Xu - Chemical reviews, 2015 - ACS Publications
In this review we intend to provide a relatively comprehensive summary of the work of
supramolecular hydrogelators after 2004 and to put emphasis particularly on the applications of …

The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets

TP Peacock, DH Goldhill, J Zhou, L Baillon… - Nature …, 2021 - nature.com
SARS-CoV-2 entry requires sequential cleavage of the spike glycoprotein at the S1/S2 and
the S2ʹ cleavage sites to mediate membrane fusion. SARS-CoV-2 has a polybasic insertion (…

Development and evaluation of an artificial intelligence system for COVID-19 diagnosis

…, L Deng, C Zheng, J Zhou, H Shi, J Feng - Nature …, 2020 - nature.com
Early detection of COVID-19 based on chest CT enables timely treatment of patients and
helps control the spread of the disease. We proposed an artificial intelligence (AI) system for …

Collagen/chitosan porous scaffolds with improved biostability for skin tissue engineering

L Ma, C Gao, Z Mao, J Zhou, J Shen, X Hu, C Han - Biomaterials, 2003 - Elsevier
Porous scaffolds for skin tissue engineering were fabricated by freeze-drying the mixture of
collagen and chitosan solutions. Glutaraldehyde (GA) was used to treat the scaffolds to …

SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion

…, A Albecka, S Singh, R Pandey, J Brown, J Zhou… - Nature, 2021 - nature.com
The B.1.617.2 (Delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
was first identified in the state of Maharashtra in late 2020 and spread throughout India, …

Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and …

…, JP Cai, WM Chan, JD Ip, AWH Chu, J Zhou… - The Lancet …, 2020 - thelancet.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported
from China in January, 2020. SARS-CoV-2 is efficiently transmitted from person to person …

Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of …

…, B Hu, X Huang, X Zhang, JP Cai, J Zhou… - Clinical Infectious …, 2020 - academic.oup.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging
coronavirus that has resulted in more than 2 000 000 laboratory-confirmed cases including …

Attenuated replication and pathogenicity of SARS-CoV-2 B. 1.1. 529 Omicron

…, Y Hou, Y Wang, L Lu, JP Cai, AJ Zhang, J Zhou… - Nature, 2022 - nature.com
The Omicron (B.1.1.529) variant of SARS-CoV-2 emerged in November 2021 and is rapidly
spreading among the human population 1 . Although recent reports reveal that the Omicron …

[HTML][HTML] Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults

…, J Zhou, K Lindsell, SS Hare, J Brown… - Nature Medicine, 2022 - nature.com
Since its emergence in 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has caused hundreds of millions of cases and continues to circulate globally. To establish …